-

$undefined

N/A

(N/A)

Alvotech :ALVO

Location: | Industry: | Sector:

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

4.51B

Cash

118.3M

Avg Qtr Burn

-66.2M

Short % of Float

0.40%

Insider Ownership

64.88%

Institutional Own.

6.27%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AVT05 (Proposed Biosimilar to Simponi® & Simponi Aria® (golimumab)) Details Inflammatory disease	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVT06, a Proposed Biosimilar to Eylea® (aflibercept) Details Eye disease	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.